Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Bombard

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annual Review of Genomics and Human Genetics|May 22, 2012
Genetic discrimination: international perspectivesM Otlowski, S Taylor, Y Bombard
Clinical Genetics|January 6, 2011
Adoption and the communication of genetic risk: experiences in Huntington diseaseY Bombard, A Semaka, M R Hayden
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Influence Of Gene Expression Profiling (GEP) On Decisional Conflict In Chemotherapy Treatment Decision-Making For Early-Stage Breast Cancer (BRCA)D Marshall, K MacDonald, K Deal, et al.
Current Oncology (Toronto, Ont.)|June 19, 2014
Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatmentY Bombard, L Rozmovits, M Trudeau, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
Patients' perceptions of gene expression profiling in breast cancer treatment decisionsY Bombard, L Rozmovits, M E Trudeau, et al.
Clinical Genetics|November 22, 2012
Knowledge of the Genetic Information Nondiscrimination act among individuals affected by Huntington diseaseE R Dorsey, K C Darwin, P E Nichols, et al.
Clinical Genetics|February 21, 2007
Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutationY Bombard, E Penziner, J Decolongon, et al.
Journal of Medical Ethics|October 2, 2009
Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screeningF A Miller, R Z Hayeems, Y Bombard, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annual Review of Genomics and Human Genetics|May 22, 2012
Genetic discrimination: international perspectivesM Otlowski, S Taylor, Y Bombard
Clinical Genetics|January 6, 2011
Adoption and the communication of genetic risk: experiences in Huntington diseaseY Bombard, A Semaka, M R Hayden
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Influence Of Gene Expression Profiling (GEP) On Decisional Conflict In Chemotherapy Treatment Decision-Making For Early-Stage Breast Cancer (BRCA)D Marshall, K MacDonald, K Deal, et al.
Current Oncology (Toronto, Ont.)|June 19, 2014
Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatmentY Bombard, L Rozmovits, M Trudeau, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
Patients' perceptions of gene expression profiling in breast cancer treatment decisionsY Bombard, L Rozmovits, M E Trudeau, et al.
Clinical Genetics|November 22, 2012
Knowledge of the Genetic Information Nondiscrimination act among individuals affected by Huntington diseaseE R Dorsey, K C Darwin, P E Nichols, et al.
Clinical Genetics|February 21, 2007
Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutationY Bombard, E Penziner, J Decolongon, et al.
Journal of Medical Ethics|October 2, 2009
Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screeningF A Miller, R Z Hayeems, Y Bombard, et al.
Pageof 1